 | | PRD_002569 | | Name: | Rufomycin analog | | Formula: | C58 H87 Cl N9 O12 | | Definition date: | 2025-04-16 | | Last modified: | 2025-04-16 |
|
 | | PRD_002560 | | Name: | Entolysin A | | Formula: | C81 H141 N17 O23 | | Description: | D-Ser, L-Val, L-Leu, D-Ser, L-Ile amino acids make up a macrocycle within the peptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002561 | | Name: | Orfamide A | | Formula: | C64 H114 N10 O17 | | Description: | Cyclic lipopeptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002568 | | Name: | Fluorinated GM1 ganglioside analogue | | Formula: | C49 H84 F2 N2 O27 | | Description: | GM1 ganglioside lipids (monosialotetrahexosylgangliosides) belong to the group of gangliosides within the sphingolipids. Their structure consists of a ceramide backbone linked to an oligosaccharide unit made of five sugar molecules. In this analogue one of the five sugars is fluorinated and the ceramide backbone is replaced by an unsaturated hydrocarbon. | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002111 | | Name: | ADEP-2B5Me | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2014-10-08 | | Last modified: | 2024-12-19 |
|
 | | PRD_002553 | | Name: | Dihydrocyclosporin A | | Formula: | C62 H113 N11 O12 | | Description: | Analogue of cyclosporine A. It is a cyclic undecapeptide. Cyclization is achieved by linking the N- and the C- termini. | | Definition date: | 2024-10-30 | | Last modified: | 2024-10-30 |
|
 | | PRD_002519 | | Name: | MCR-PHE-VAL-PRO-THR-THR-BIF-MAA-BIF-MAA-GLU-ALA-PRO-ALA-NEH inhibitor | | Formula: | C85 H110 N14 O18 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002521 | | Name: | YBX-YC3-VAL-PRO-THR-THR-PHE-MAA-CYS-MN1 inhibitor | | Formula: | C60 H81 N9 O13 S3 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002558 | | Name: | DGN-DVA-YC3-GLU-PRO-THR-THR-PHE-MAA-A1BC0 inhibitor | | Formula: | C62 H84 N12 O14 S2 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002562 | | Name: | MCR-ALA-7T2-GLY-004-7T2-SER-7T2-ALA-GLY-NH2 inhibitor | | Formula: | C53 H61 Cl3 N10 O11 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002583 | | Name: | Peptidoglycan disaccharide tetrapeptide | | Formula: | C37 H63 N9 O19 | | Description: | Peptidoglycan is composed of glycan strands and peptide stems. In this instance the glycan strands are made of N-acetylmuramic acid/MurNAc (MUB) and N-acetylglucosamine/GlcNAc (NAG) linked by beta-1,4 glycosidic bonds. Peptide stems, in this instance, are attach to MurNAc and consist of L-alanine, gamma D-glutamine/D-Gln (ZGL), meso-diaminopimelic acid/m-DAP (JGO), and D-alanine (DAP). | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002234 | | Formula: | C57 H91 N12 O19 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_002420 | | Name: | G2S2-oxazoline | | Formula: | C76 H124 N5 O56 | | Definition date: | 2024-07-03 | | Last modified: | 2024-07-03 |
|
 | | PRD_002429 | | Name: | cihanmycin G | | Formula: | C74 H87 N11 O22 | | Definition date: | 2024-06-19 | | Last modified: | 2024-06-19 |
|
 | | PRD_002404 | | Name: | Dynobactin A | | Formula: | C60 H78 N18 O16 | | Description: | 10mer peptide with distinct cyclophane rings. | | Definition date: | 2022-09-28 | | Last modified: | 2024-03-26 |
|
 | | PRD_002532 | | Name: | N-Methyl-D-Gln4,Lys10-teixobactin | | Formula: | C59 H100 N13 O15 | | Definition date: | 2024-03-06 | | Last modified: | 2024-03-06 |
|
 | | PRD_002533 | | Name: | Deacylated Microviridin J | | Formula: | C67 H97 N17 O20 | | Definition date: | 2024-02-14 | | Last modified: | 2024-02-14 |
|
 | | PRD_000671 | | Name: | PHQ-ILE-GLU-THR-azaASP-EP-CO-ALA-NH-CH2-PH | | Formula: | C39 H53 N7 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2024-01-09 |
|
 | | PRD_002466 | | Name: | Cyclohexyl-Griselimycin | | Formula: | C63 H106 N10 O12 | | Definition date: | 2023-11-29 | | Last modified: | 2023-11-29 |
|
 | | PRD_002467 | | Name: | Mycoplanecin A | | Formula: | C61 H102 N10 O13 | | Definition date: | 2023-11-29 | | Last modified: | 2023-11-29 |
|
 | | PRD_000001 | | Name: | Actinomycin D | | Formula: | C62 H86 N12 O16 | | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000006 | | Name: | 8-Fluoro-Actinomycin D | | Formula: | C62 H85 F N12 O16 | | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXF)
THE CHROMOPHORE PXF IS A MODIFIED PXZ WITH
C-F REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000007 | | Name: | Actinomycin X2 | | Formula: | C62 H84 N12 O17 | | Description: | ACTINOMYCIN X2 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000896 | | Name: | MM-402 | | Formula: | C31 H51 N8 O5 | | Definition date: | 2014-02-19 | | Last modified: | 2023-11-03 |
|
 | | PRD_000009 | | Name: | Actinomycin Z3 | | Formula: | C62 H83 Cl N12 O18 | | Description: | ACTINOMYCIN Z3 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
